Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about ATAXIA: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
ATAXIA is a concept in neurodegeneration research. Key relationships include: activates, co discussed, transports. Associated with ALS, ALZHEIMER, ALZHEIMER'S. Connected to 50 entities in the SciDEX knowledge graph.
No AI portrait yet
| Name | ATAXIA |
| Key Genes/Proteins | ACHE, AMPK, ATG7, BCL2, BECN1, CGAS |
| Related Diseases | ALS, ALZHEIMER, ALZHEIMER'S, ALZHEIMER'S DISEASE, AMYOTROPHIC LATERAL SCLEROSIS |
Knowledge base pages for this entity
graph TD
ATAXIA["ATAXIA"]
ATAXIA -->|"target for"| Immune_Response["Immune Response"]
ATAXIA -->|"activates"| Oxidative_Stress["Oxidative Stress"]
ATAXIA -->|"target for"| Mitochondrial_Function["Mitochondrial Function"]
CALCINEURIN["CALCINEURIN"] -->|"activates"| ATAXIA
ATG12["ATG12"] -->|"activates"| ATAXIA
ATG10["ATG10"] -->|"activates"| ATAXIA
HSPA1A["HSPA1A"] -->|"regulates"| ATAXIA
DNAJB1["DNAJB1"] -->|"regulates"| ATAXIA
GENES["GENES"] -->|"activates"| ATAXIA
DNA["DNA"] -->|"target for"| ATAXIA| Target | Relation | Type | Str |
|---|---|---|---|
| Als | associated_with | disease | 0.95 |
| Amyotrophic Lateral Sclerosis | associated_with | disease | 0.95 |
| Parkinson | associated_with | disease | 0.85 |
| Neurodegeneration | implicated_in | disease | 0.85 |
| Dementia | associated_with | disease | 0.75 |
| Neurodegeneration | associated_with | disease | 0.75 |
| Parkinson | activates | disease | 0.75 |
| Mitochondrial Function | inhibits | pathway | 0.70 |
| Oxidative Stress | activates | pathway | 0.70 |
| PURKINJE | sensitizes_to | cell_type | 0.65 |
| SQSTM1 | activates | gene | 0.65 |
| Parkinson | causes | disease | 0.65 |
| CEREBELLUM | reduces | brain_region | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Alzheimer | associated_with | disease | 0.65 |
| Neurodegeneration | regulates | disease | 0.65 |
| Als | implicated_in | disease | 0.65 |
| ROS | regulates | gene | 0.65 |
| FRONTOTEMPORAL DEMENTIA | exacerbates | disease | 0.65 |
| RAPAMYCIN | interacts_with | drug | 0.65 |
| FRONTOTEMPORAL DEMENTIA | transports | disease | 0.65 |
| Aging | associated_with | disease | 0.65 |
| Neuroinflammation | therapeutic_target | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Inflammation | therapeutic_target | disease | 0.65 |
| Alzheimer | activates | disease | 0.65 |
| Stroke | associated_with | disease | 0.65 |
| Multiple Sclerosis | associated_with | disease | 0.65 |
| LEVODOPA | mediates | drug | 0.65 |
| ROS | phosphorylates | gene | 0.65 |
| Oxidative Stress | associated_with | pathway | 0.60 |
| Apoptosis | associated_with | pathway | 0.60 |
| Mtor | associated_with | pathway | 0.60 |
| Autophagy | associated_with | pathway | 0.60 |
| Senescence | inhibits | pathway | 0.60 |
| Immune Response | treats | pathway | 0.60 |
| Mitochondrial Function | implicated_in | pathway | 0.60 |
| PARKINSON'S | activates | disease | 0.60 |
| PARKINSON'S DISEASE | activates | disease | 0.60 |
| STING | activates | gene | 0.60 |
| Stem Cell | associated_with | pathway | 0.60 |
| CGAS | activates | gene | 0.60 |
| PARKIN | mediates | gene | 0.60 |
| NEURON | mediates | cell_type | 0.60 |
| MOTOR NEURON | mediates | cell_type | 0.60 |
| Mitochondrial Function | therapeutic_target | pathway | 0.60 |
| PARKINSON'S DISEASE | mediates | disease | 0.60 |
| PARKINSON'S | mediates | disease | 0.60 |
| PARKINSON | mediates | disease | 0.60 |
| PARKINSON | activates | disease | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| AMYOTROPHIC LATERAL SCLEROSIS | associated_with | gene | 1.00 |
| DEMENTIA | associated_with | gene | 0.95 |
| NEURODEGENERATION | implicated_in | gene | 0.95 |
| HUNTINGTON | associated_with | gene | 0.95 |
| PARKINSON | associated_with | gene | 0.95 |
| GENES | activates | gene | 0.95 |
| DNA | associated_with | gene | 0.85 |
| Stress Granule Formation | protects_against | process | 0.85 |
| ALS | associated_with | gene | 0.85 |
| PARKINSON | activates | gene | 0.85 |
| CANCER | activates | gene | 0.85 |
| NEURODEGENERATION | associated_with | gene | 0.85 |
| ATM | activates | gene | 0.85 |
| Huntington | associated_with | disease | 0.85 |
| DNA | activates | gene | 0.85 |
| Reducing Stress Granule Formation | contributes_to | process | 0.85 |
| DNA | therapeutic_target | gene | 0.75 |
| ENDOSOMES | associated_with | gene | 0.75 |
| NRF2 | therapeutic_target | gene | 0.75 |
| SCA3 | associated_with | gene | 0.75 |
| HUNTINGTON'S DISEASE | associated_with | gene | 0.75 |
| NEURODEGENERATIVE DISORDERS | associated_with | gene | 0.75 |
| ALZHEIMER | associated_with | gene | 0.75 |
| NEURODEGENERATION | regulates | gene | 0.75 |
| GAIN | implicated_in | gene | 0.75 |
| ATXN1 | causes | gene | 0.75 |
| PARKINSON'S DISEASE | associated_with | gene | 0.75 |
| BDNF | protects_against | gene | 0.75 |
| NEURODEGENERATIVE DISEASES | associated_with | gene | 0.75 |
| AMYLOID | implicated_in | gene | 0.75 |
| MITOPHAGY | inhibits | gene | 0.75 |
| DRP1 | associated_with | gene | 0.75 |
| APP | implicated_in | gene | 0.75 |
| HUNTINGTON | activates | gene | 0.75 |
| C9ORF72 | associated_with | gene | 0.75 |
| ALZHEIMER | activates | gene | 0.75 |
| NEURODEGENERATIVE DISEASES | therapeutic_target | gene | 0.75 |
| P53 | activates | gene | 0.75 |
| NEUROINFLAMMATION | therapeutic_target | gene | 0.75 |
| POLG | associated_with | gene | 0.75 |
| OXIDATIVE STRESS | activates | gene | 0.75 |
| STAU1 | associated_with | gene | 0.65 |
| SIL1 | associated_with | gene | 0.65 |
| FMR1 | associated_with | gene | 0.65 |
| NEURODEGENERATION | protects_against | gene | 0.65 |
| CLPP | associated_with | gene | 0.65 |
| MAP1LC3 | associated_with | gene | 0.65 |
| GENES | causes | gene | 0.65 |
| MITOCHONDRIAL DYSFUNCTION | therapeutic_target | gene | 0.65 |
| WFS1 | associated_with | gene | 0.65 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity